Northwire Canada EditionSunday, July 19, 2026
Sign inSubscribe
Northwire
⌕
AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0% AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0%

Healthcare

Page 122
  1. Oct 08, 2025 · 08:00 · QNTM

    Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

    Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

    01
  2. Oct 08, 2025 · 08:00 · AIDR

    Rocket Doctor Signs Contracts with Major U.S. Insurers, Expanding Access to Over 7 Million Patients Across California and New York

    Rocket Doctor Signs Contracts with Major U.S. Insurers, Expanding Access to Over 7 Million Patients Across California and New York

    02
  3. Oct 08, 2025 · 03:45 · UDOC

    Unidoc arranges $1.5-million private placement

    Unidoc arranges $1.5-million private placement

    03
  4. Oct 08, 2025 · 03:40 · HEM

    Hemostemix receives $330,000 lead order for placement

    Hemostemix receives $330,000 lead order for placement

    04
  5. Oct 07, 2025 · 20:27 · BUX

    Biomark platform selected for German lung cancer trial

    Biomark platform selected for German lung cancer trial

    05
  6. Oct 07, 2025 · 17:49 · GENX

    Genix Pharmaceuticals Issues Clarification to Previously Announced Private Placement Terms

    Genix Pharmaceuticals Issues Clarification to Previously Announced Private Placement Terms

    06
  7. Oct 07, 2025 · 17:30 · BIOV

    BIOVAXYS ANNOUNCES LIFE OFFERING

    BIOVAXYS ANNOUNCES LIFE OFFERING

    07
  8. Oct 07, 2025 · 17:20 · PRN

    Profound estimates Q3 revenue of $5.2-million (U.S.)

    Profound estimates Q3 revenue of $5.2-million (U.S.)

    08
  9. Oct 07, 2025 · 17:04 · GUD

    Knight Therapeutics relaunches Orgovyx in Canada

    Knight Therapeutics relaunches Orgovyx in Canada

    09
  10. Oct 07, 2025 · 17:01 · GUD

    Knight Therapeutics relaunches Myfembree in Canada

    Knight Therapeutics relaunches Myfembree in Canada

    10
  11. Oct 07, 2025 · 10:37 · UDOC

    RETRANSMISSION UniDoc Announces LIFE Offering

    RETRANSMISSION UniDoc Announces LIFE Offering

    11
  12. Oct 07, 2025 · 10:05 · HEM

    Hemostemix's Insider Lead Order of $330,000 Private Placement

    Hemostemix's Insider Lead Order of $330,000 Private Placement

    12
  13. Oct 07, 2025 · 08:32 · PNGA

    Pangea Provides Corporate Update on Peptide Products and Delivery System Pipeline

    Pangea Provides Corporate Update on Peptide Products and Delivery System Pipeline

    13
  14. Oct 07, 2025 · 08:31 · BUX

    BioMark's Liquid Biopsy Platform Selected for Holistic German Lung Cancer Screening Trial

    BioMark's Liquid Biopsy Platform Selected for Holistic German Lung Cancer Screening Trial

    14
← Newer Older →